Grufity logoGrufity logo

PHR

27.82USD+2.18(+8.50%)Market Closed

Phreesia, Inc.

Market Summary

USD27.82+2.18Market Closed
8.50%

PHR Alerts

PHR Stock Price

RSI Chart

Valuation

Market Cap

1.5B

Price/Earnings

-8.12

Price/Sales

5.99

Price/Cashflow

-12.66

MarketCap/EBT

-8.13

Price/Sales

Profitability

EBT Margin

-73.65%

Return on Equity

-51.87%

Return on Assets

-42.43%

Fundamentals

Revenue

Revenue (TTM)

245.2M

Revenue Y/Y

33.05%

Revenue Q/Q

7.12%

Earnings

Earnings (TTM)

-180.8M

Earnings Y/Y

-91.51%

Earnings Q/Q

8.83%

Price Action

52 Week Range

59.13
(Low)(High)

Last 7 days

11.4%

Last 30 days

1.8%

Last 90 days

13.9%

Trailing 12 Months

-51.8%

Financial Health

Current Ratio

4.4

Debt/Equity

5e-4

Debt/Cashflow

-734.08

Investor Care

Shares Dilution (1Y)

3.26%

Diluted EPS (TTM)

-3.52

Peers (Alternatives to Phreesia)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
1.5T
2.6B
-3.53% 36.77%
6.7K
569.2
138.91% 529.87%
515.6B
315.1B
-1.33% 24.91%
28.25
1.68
12.82% 25.96%
27.9B
5.8B
0.98% 20.75%
47.36
4.81
5.93% -26.79%
26.5B
2.0B
13.35% -32.64%
67.34
13.25
20.29% -7.22%
MID-CAP
9.0B
3.5B
11.88% 31.28%
-117.28
2.58
7.15% -34.72%
4.8B
2.3B
-3.81% -71.84%
-0.48
2.14
24.79% -1114.68%
3.5B
1.3B
-33.25% -70.84%
56.99
2.75
22.34% -40.14%
SMALL-CAP
1.6B
837.2M
28.84% 13.89%
26.25
1.55
-33.83% -91.80%
1.5B
245.2M
1.83% -51.77%
-8.12
5.99
36.52% -260.24%
1.3B
613.7M
3.79% 34.19%
65.1
2.15
5.58% 602.90%
862.9M
53.9M
-2.19% -13.45%
69.12
16.01
16.01% 27.61%
745.9M
262.6M
2.83% 9.39%
80.59
2.84
3.32% 29.35%
500.7M
271.8M
18.82% -75.85%
-3.46
1.89
17.92% -2.29%
278.8M
63.1M
36.81% -67.55%
-39.93
4.35
9.93% -1043.45%
94.0M
302.5M
14.80% -60.42%
-0.81
0.3
-0.73% -57.66%

Financials for Phreesia

Income Statement (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Revenue7.4%245228213197180
  S&GA Expenses12.3%1481311068261
  R&D Expenses17.1%7665524132
Earnings Before Taxes-14.2%-180.56-158.16-117.98-79.51-49.87
Net Income-14.1%-180.75-158.43-118.16-79.81-50.18
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Assets-7.2%426459494529551
  Current Assets-9.4%316349386464494
    Cash Equivalents-10.6%241269314400440
  Goodwill0.6%34343488
Liabilities-0.4%7878777165
  Current Liabilities1.7%7271686558
  Long Term Debt-71.0%01010
Shareholder's Equity-8.6%348381417458487
  Retained Earnings-9.7%-527.90-481.18-429.94-383.49-347.14
  Additional Paid-In Capital1.8%896881861849840
Shares Outstanding1.8%525151--
Float-3,561----
* denotes actual numbers (not divided by Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Cashflow From Operations-12.7%-115.98-102.87-74.71-32.65-8.79
  Share Based Compensation16.4%5245363020
Cashflow From Investing-4.1%-68.05-65.35-65.23-38.54-27.74
Cashflow From Financing-13.7%-15.09-13.27235217392

Risks

What is the probability of a big loss on PHR?

80.2%


Probability that Phreesia stock will be more than 20% underwater in next one year

79.1%


Probability that Phreesia stock will be more than 30% underwater in next one year.

74.0%


Probability that Phreesia stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does PHR drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Phreesia was unfortunately bought at previous high price.

Returns

Cumulative Returns on PHR

-0.4%


3-Year Cumulative Returns

Which funds bought or sold PHR recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2022-11-22
Capital Impact Advisors, LLC
-
-
25,000
488,000
0.49%
2022-11-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
-
-
19,000
1,581,000
-%
2022-11-21
FourThought Financial, LLC
-
-
13,000
79,000
0.01%
2022-11-17
M Holdings Securities, Inc.
UNCHANGED
-
10,000
539,000
0.06%
2022-11-16
CAPTRUST FINANCIAL ADVISORS
SOLD OFF
-100
-36,000
-
-%
2022-11-15
NOMURA HOLDINGS INC
NEW
-
27,000
27,000
-%
2022-11-15
ALLIANCEBERNSTEIN L.P.
ADDED
107.6
1,576,000
2,989,000
-%
2022-11-15
JANE STREET GROUP, LLC
NEW
-
297,000
297,000
-%
2022-11-15
ALGERT GLOBAL LLC
NEW
-
1,852,000
1,852,000
0.11%
2022-11-15
CONCOURSE FINANCIAL GROUP SECURITIES, INC.
SOLD OFF
-
-
-
-%

1–10 of 45

Latest Funds Activity

Are funds buying PHR calls or puts?
Are funds bullish or bearish(Calls - Puts)?
No. of funds that own PHR

Phreesia News

MarketBeat

Phreesia (PHR) Scheduled to Post Quarterly Earnings on Thursday.67 minutes ago

PHR Fair Value

Recent SEC filings of Phreesia

View All Filings
Date Filed Form Type Document
Nov 08, 2022
4
Insider Trading
Nov 04, 2022
4
Insider Trading
Nov 02, 2022
4
Insider Trading
Nov 02, 2022
4
Insider Trading
Nov 02, 2022
4
Insider Trading
Oct 19, 2022
4
Insider Trading
Oct 18, 2022
4
Insider Trading
Oct 18, 2022
4
Insider Trading
Oct 18, 2022
4
Insider Trading
Oct 18, 2022
4
Insider Trading

Latest Insider Trading transactions for PHR

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-11-06
Rasmussen Randy
SOLD FOR TAXES
-137,180
24.34
-5,636
Chief Financial Officer
2022-11-02
VanDuyn Amy Beth
SOLD
-518,958
26.832
-19,341
SVP, Human Resources
2022-10-31
Munson Gillian
ACQUIRED
9,999.12
27.32
366
-
2022-10-31
Goldstein Lainie
ACQUIRED
9,999.12
27.32
366
-
2022-10-31
CAHILL EDWARD L
ACQUIRED
9,999.12
27.32
366
-
2022-10-18
Davidoff Michael J.
SOLD
-27,154.5
25.26
-1,075
SVP, Payer Business
2022-10-14
Roberts Evan
SOLD FOR TAXES
-48,107.2
22.48
-2,140
Chief Operating Officer
2022-10-14
Indig Chaim
SOLD FOR TAXES
-82,276.8
22.48
-3,660
Chief Executive Officer
2022-10-14
Rasmussen Randy
SOLD FOR TAXES
-27,403.1
22.48
-1,219
Chief Financial Officer
2022-10-14
VanDuyn Amy Beth
SOLD FOR TAXES
-14,005
22.48
-623
SVP, Human Resources

1–10 of 50

Chaim Indig
1700
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Raleigh, North Carolina.

PHR Income Statement

2022-07-31
Unaudited Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended6 Months Ended
Jul. 31, 2022
Jul. 31, 2021
Jul. 31, 2022
Jul. 31, 2021
Revenue:    
Total revenues$ 67,867$ 51,007$ 131,221$ 99,298
Expenses:    
Cost of revenue (excluding depreciation and amortization)14,87310,03229,25918,566
Payment processing expense12,5549,64824,71219,373
Sales and marketing38,34122,16778,37237,179
Research and development22,54211,44343,17719,497
General and administrative20,07316,24440,92828,915
Depreciation4,2203,7018,4986,998
Amortization1,5991,5803,2033,231
Total expenses114,20274,815228,149133,759
Operating loss(46,335)(23,808)(96,928)(34,461)
Other income (expense), net38(90)7(24)
Interest (expense) income, net(206)(207)(589)(445)
Total other expense, net(168)(297)(582)(469)
Loss before provision for income taxes(46,503)(24,105)(97,510)(34,930)
Provision for income taxes(213)(288)(448)(437)
Net loss$ (46,716)$ (24,393)$ (97,958)$ (35,367)
Net loss per share attributable to common stockholders - basic (in dollars per share)$ (0.89)$ (0.48)$ (1.88)$ (0.73)
Net loss per share attributable to common stockholders - diluted (in dollars per share)$ (0.89)$ (0.48)$ (1.88)$ (0.73)
Weighted-average common shares outstanding - basic (in shares)52,325,20950,577,61452,135,25048,287,305
Weighted-average common shares outstanding - diluted (in shares)52,325,20950,577,61452,135,25048,287,305
Subscription and related services    
Revenue:    
Total revenues$ 31,069$ 22,885$ 60,170$ 44,704
Payment processing fees    
Revenue:    
Total revenues19,58116,30638,96232,950
Life sciences    
Revenue:    
Total revenues$ 17,217$ 11,816$ 32,089$ 21,644

PHR Balance Sheet

2022-07-31
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jul. 31, 2022
Jan. 31, 2022
Current:  
Cash and cash equivalents$ 240,729$ 313,812
Settlement assets19,72519,590
Accounts receivable, net of allowance for doubtful accounts of $1,029 and $863 as of July 31, 2022 and January 31, 2022, respectively46,95840,262
Deferred contract acquisition costs1,3631,642
Prepaid expenses and other current assets7,72111,043
Total current assets316,496386,349
Property and equipment, net of accumulated depreciation and amortization of $61,661 and $53,321 as of July 31, 2022 and January 31, 2022, respectively28,55834,645
Capitalized internal-use software, net of accumulated amortization of $33,809 and $31,139 as of July 31, 2022 and January 31, 2022, respectively27,52217,643
Operating lease right-of-use assets1,3152,337
Deferred contract acquisition costs1,9882,437
Intangible assets, net of accumulated amortization of $1,864 and $1,178 as of July 31, 2022 and January 31, 2022, respectively12,08612,772
Deferred tax asset75515
Goodwill33,83633,621
Other assets4,1124,157
Total Assets425,988494,476
Current:  
Settlement obligations19,72519,590
Current portion of finance lease liabilities and other debt5,7175,821
Current portion of operating lease liabilities1,2981,281
Accounts payable10,0885,119
Accrued expenses17,92520,128
Deferred revenue17,19516,493
Total current liabilities71,94868,432
Long-term finance lease liabilities and other debt4,9337,423
Operating lease liabilities, non-current6331,276
Long-term deferred revenue1065
Total Liabilities77,52477,196
Commitments and contingencies (Note 11)
Stockholders’ Equity:  
Common stock, $0.01 par value - 500,000,000 shares authorized as of both July 31, 2022 and January 31, 2022; 53,072,838 and 52,095,964 shares issued as of July 31, 2022 and January 31, 2022, respectively531521
Additional paid-in capital896,264860,657
Accumulated deficit(527,896)(429,938)
Treasury stock, at cost, 563,428 and 301,003 shares as of July 31, 2022 and January 31, 2022, respectively(20,435)(13,960)
Total Stockholders’ Equity348,464417,280
Total Liabilities and Stockholders’ Equity$ 425,988$ 494,476